Efficacy, safety, and tolerability of ipragliflozin in Asian patients with type 2 diabetes mellitus and inadequate glycemic control with metformin: Results of a phase 3 randomized, placebo-controlled, double-blind, multicenter trial. (Q36843902)
Jump to navigation
Jump to search
scientific article published on 14 October 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy, safety, and tolerability of ipragliflozin in Asian patients with type 2 diabetes mellitus and inadequate glycemic control with metformin: Results of a phase 3 randomized, placebo-controlled, double-blind, multicenter trial. |
scientific article published on 14 October 2015 |
Statements
Efficacy, safety, and tolerability of ipragliflozin in Asian patients with type 2 diabetes mellitus and inadequate glycemic control with metformin: Results of a phase 3 randomized, placebo-controlled, double-blind, multicenter trial (English)
Chieh-Hsiang Lu
Kyung Wan Min
Satoshi Kokubo
Satoshi Yoshida
14 October 2015